RVL Pharmaceuticals plc Banner Image

RVL Pharmaceuticals plc

  • Ticker RVLP
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
RVL Pharmaceuticals plc Logo Image
  • 201-500 Employees
  • Based in Bridgewater, New Jersey
RVL Pharmaceuticals plc is a specialty pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas. The Company is currently commercializing UPNEEQ® (oxymetazoline hydrocholoride ophthalmic solution), 0.1%, for the treatment of acquired blepharoptosisMore, or low-lying eyelid, in adults. UPNEEQ is the first non-surgical treatment option approved by the FDA for acquired blepharoptosis.
4.8 / 5.0 (168)

RVL Pharmaceuticals plc reports have an aggregate usefulness score of 4.8 based on 168 reviews.

RVL Pharmaceuticals plc

Most Recent Annual Report

RVL Pharmaceuticals plc
MOST RECENT 2022 Annual Report

Older/Archived Annual Reports

RVL Pharmaceuticals plc Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!